跳至主要内容
临床试验/IRCT20091114002709N50
IRCT20091114002709N50招募中3 期

The effect of curcumin supplementation on glycemic control, antioxidant and anthropomethric indices, PGC1-a and SIRT1 gene expression in polycystic ovary syndrome(PCOS) women

Iran University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
Female

入选标准

  • The willingness to voluntarily participate in the study
  • Diagnosis of polycystic ovary syndrome by a specialist physician in the mild to moderate phase
  • Having impaired glucose tolerance (IGT)
  • The consumer is just one of the metformin or clomiphene drug groups
  • Age more than 18 years old
  • BMI higher than 25 and less than 30 kg/m2

排除标准

  • Change the type and dosage of the drug over the past month
  • Congenital hormonal disorders, autoimmune diseases, cancer, inflammatory diseases, hyperthyroidism and hypothyroidism, infections, pregnancy or lactation in women, or use of contraceptive pills
  • The use of multi-vitamin-mineral, omega-3, polyphenolic and antioxidant supplements, as well as the use of anticoagulants such as heparin and warfarin or aspirin, blood cholesterol-lowering drugs (statins), NSAIDs, such as ipobrofen, aspirin and diclofenac, Antihistamines, calcium channel antagonists such as nifedipine, anti-TNF drugs (infliximab, adalimumab and cinnura), glucocorticosteroids (cortisone, prednisolone) and spironolactone during in the past month.

研究者

相似试验